You just read:

Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study of Apealea/Paclical for Treatment of Ovarian Cancer

News provided by

Oasmia Pharmaceutical AB

27 Apr, 2016, 07:30 BST